Pecam-1 expression in patients with relapsing-remitting multiple sclerosis.

Area of Science:

• Immunology and Neuroscience
• Cell Adhesion Molecules
• Multiple Sclerosis Pathophysiology

Background:

• Platelet endothelial cell adhesion molecule-1 (PECAM-1) is an immunoglobulin superfamily member mediating leukocyte transendothelial migration.
• PECAM-1 is expressed on leukocytes (lymphocytes, monocytes, granulocytes), endothelial cells, and platelets.
• Understanding PECAM-1's role in inflammatory conditions like multiple sclerosis (MS) is crucial.

Purpose of the Study:

• To investigate the expression levels of cell-bound PECAM-1 in patients with multiple sclerosis (MS).
• To determine if PECAM-1 expression correlates with MS disease activity, particularly MRI-defined lesions.

Main Methods:

• Flow cytometry was used to quantify cell-bound PECAM-1 expression on monocytes and lymphocytes.
• Comparison of PECAM-1 levels between MS patients and healthy controls.
• Correlation analysis between PECAM-1 expression and the presence of gadolinium-enhancing MRI lesions in MS patients.

Main Results:

• Cell-bound PECAM-1 expression on monocytes was significantly increased in MS patients compared to controls.
• PECAM-1 was significantly over-expressed on lymphocytes in MS patients with active MRI lesions (gadolinium-enhancing) versus those without.
• These findings indicate altered PECAM-1 expression patterns in MS.

Conclusions:

• Increased cell-bound PECAM-1 expression on monocytes and lymphocytes is associated with multiple sclerosis.
• PECAM-1 over-expression, especially on lymphocytes, correlates with active MS lesions on MRI.
• Cell-bound PECAM-1 shows potential as a biomarker for assessing MS disease activity.